Add-on Acquisition • Life Science

Bruker Acquires BIOCRATES

On June 3, 2025, Bruker acquired life science company BIOCRATES

Acquisition Context

This is Bruker’s 5th transaction in the Life Science sector.
This is Bruker’s 2nd transaction in Austria.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	June 3, 2025
Target	BIOCRATES
Sector	Life Science
Buyer(s)	Bruker
Deal Type	Add-on Acquisition

Target Company

BIOCRATES

Innsbruck, Austria

BIOCRATES is a provider of endogenous and exogenous small molecules such as lipids or amino acids, called metabolites. BIOCRATES was founded in 2002 and is based in Innsbruck, Austria.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Bruker

Billerica, Massachusetts, United States

Category	Company
Founded	1991
Sector	Test/Measurement Equipment
Employees	11,396
Revenue	3.4B USD (2024)

DESCRIPTION

Bruker is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. Bruker was founded in 1991 and is based in Billerica, Massachusetts.

Deal Context for Buyer	#
Overall	48 of 48
Sector: Life Science	5 of 5
Type: Add-on Acquisition	43 of 43
Country: Austria	2 of 2
Year: 2025	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2024-04-17	NanoString Technologies Seattle, Washington, United States NanoString Technologies develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. NanoString Technologies was founded in 2003 and is based in Seattle, Washington.	Buy	$393M

DATE

TARGET

DEAL TYPE

VALUE

2024-04-17

NanoString Technologies

Seattle, Washington, United States

NanoString Technologies develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. NanoString Technologies was founded in 2003 and is based in Seattle, Washington.

Buy

$393M

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Austria M&A - 2025 M&A